Abstract
Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.
| Original language | English |
|---|---|
| Pages (from-to) | 116-120 |
| Number of pages | 5 |
| Journal | Tumori |
| Volume | 104 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jan 1 2018 |
Fingerprint
Keywords
- Breast cancer
- Estimates
- Italy
- Metastasis
- Stage IV
ASJC Scopus subject areas
- Medicine(all)
Cite this
Metastatic breast cancers : Estimates for Italy. / Crocetti, Emanuele; Gori, Stefania; Falcini, Fabio.
In: Tumori, Vol. 104, No. 2, 01.01.2018, p. 116-120.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Metastatic breast cancers
T2 - Estimates for Italy
AU - Crocetti, Emanuele
AU - Gori, Stefania
AU - Falcini, Fabio
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.
AB - Purpose: Breast is the leading site of cancer onset and death in Italy. Cases diagnosed in stage IV or that progress in metastatic phase represent a specific and challenging task for oncologists. Estimates on the burden of breast cancer (BC) in stage IV in Italy are not available. Methods: We applied mortality-incidence age-specific ratios measured in the United States in 2013 for BC in stage IV at diagnosis (de novo) or following a previous diagnosis in a localized stage (distant recurrence) to the age-specific BC deaths observed in Italy in 2014. The US mortality-prevalence age-specific ratios were used for estimating de novo and distant recurrence prevalent metastatic BC. Results: In 2014 in Italy, there were 12,330 deaths due to BC. We estimated that in the same year about 3400 BC were newly diagnosed in stage IV (7.1% of all the new cases); moreover, more than 10,000 other BC progressed to stage IV. In addition, in 2014, the overall number of BC in stage IV, whenever diagnosed, was about 37,100 (5.6% of all the estimated prevalent BC). Conclusions: These estimates quantify, for the first time in Italy, the burden of BC in stage IV, at diagnosis or during the clinical course, providing useful figures for clinicians and policy makers.
KW - Breast cancer
KW - Estimates
KW - Italy
KW - Metastasis
KW - Stage IV
UR - http://www.scopus.com/inward/record.url?scp=85050188495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050188495&partnerID=8YFLogxK
U2 - 10.1177/0300891618766177
DO - 10.1177/0300891618766177
M3 - Article
C2 - 29714648
AN - SCOPUS:85050188495
VL - 104
SP - 116
EP - 120
JO - Tumori
JF - Tumori
SN - 0300-8916
IS - 2
ER -